Stock Sale, Buyback News

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis has also granted the initial purchasers of the Notes an o...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

HOUSTON--(BUSINESS WIRE)--WM (NYSE: WM) today announced that its Board of Directors has approved a capital allocation program that includes a planned 14.5% increase in the 2026 dividend rate and a new $3 billion share repurchase authorization, superseding the authority remaining under the prior $1.5 billion repurchase authorization announced in 2023. The planned quarterly dividend rate of $0.945 per share in 2026, up from $0.825 per share in 2025, marks the twenty-third consecutive year of divi...

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common shares of the Company (the "Options") with an effective grant date of December 15, 2025. The Options have an exercise price...

MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted an equity award on December 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Financial Officer, Amy O’Keefe. As previously disclosed, in connection with the appointment of O’Keefe as Executive Vice President and Chief Financial Officer effective December 8, 2025, Sleep Number granted O’Keefe an employment inducement award consi...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $400 million of shares of its common stock. All of the shares are being offered by Immunome. In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (LEI: 529900S21EQ1BO4ESM68) (Paris:TTE) (LSE:TTE) (NYSE:TTE) declares the following purchases of its own shares (FR0000120271) from December 8 to December 12, 2025: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares...

LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR): Aggregated presentation by day and by market Name of the issuer Identity code of the Issuer Day of the transaction  Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares* Market (MIC Code) LEGRAND SA 969500XXRPGD7HCAFA90 11-Dec-25 FR0010307819 62 583 126,3241 XPAR LEGRAND SA 969500XXRPGD7HCAFA90 11-Dec-25 FR0010307819 27 000 126,0555 DXE LEGRAND...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 08/12/2025 FR0014000MR3 20 000 57.9041 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/12/2025 FR0014000MR3 20 000 57.0435 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/1...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the per...